Freshfields Helps Novartis Buy German Pharma In €2.7B Deal
Swiss pharmaceutical giant Novartis AG has agreed to buy MorphoSys AG in a deal that values the German biopharmaceutical group at €2.7 billion ($2.9 billion) as it seeks to develop its...To view the full article, register now.
Already a subscriber? Click here to view full article